UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Antidepressant medications: a review of the evidence for drug-induced sexual dysfunction

Journal of affective disorders, 2002-05, Vol.69 (1), p.119-140

2002

Volltextzugriff (PDF)

A Randomised Study Comparing Escitalopram with Venlafaxine XR in Primary Care Patients with Major Depressive Disorder

Neuropsychobiology, 2004-01, Vol.50 (1), p.57-64

2004

Volltextzugriff (PDF)

Absence of discontinuation symptoms with agomelatine and occurrence of discontinuation symptoms with paroxetine: a randomized, double-blind, placebo-controlled discontinuation study

International clinical psychopharmacology, 2004-09, Vol.19 (5), p.271-280

2004

Volltextzugriff (PDF)

Disabilities and quality of life in pure and comorbid generalized anxiety disorder and major depression in a national survey

International clinical psychopharmacology, 2000-11, Vol.15 (6), p.319-328

2000

Volltextzugriff (PDF)

Citalopram 20 mg, 40 mg and 60 mg are all effective and well tolerated compared with placebo in obsessive-compulsive disorder

International clinical psychopharmacology, 2001-03, Vol.16 (2), p.75-86

2001

Volltextzugriff (PDF)

Safety of mirtazapine: a review

International clinical psychopharmacology, 1995-12, Vol.10 Suppl 4 (Supplement 4), p.37-45

Montgomery, S A

1995

Volltextzugriff (PDF)

Social phobia: diagnosis and epidemiology, neurobiology and pharmacology, comorbidity and treatment

Journal of affective disorders, 2000-10, Vol.60 (1), p.61-74

2000

Volltextzugriff (PDF)

Paroxetine is better than placebo in relapse prevention and the prophylaxis of recurrent depression

International clinical psychopharmacology, 1993, Vol.8 (3), p.189-196

1993

Volltextzugriff (PDF)

A meta-analysis of the efficacy and tolerability of paroxetine versus tricyclic antidepressants in the treatment of major depression

International clinical psychopharmacology, 2001-05, Vol.16 (3), p.169-178

Montgomery, S A

2001

Volltextzugriff (PDF)

Mirtazapine versus amitriptyline in the long-term treatment of depression: a double-blind placebo-controlled study

International clinical psychopharmacology, 1998-03, Vol.13 (2), p.63-74

1998

Volltextzugriff (PDF)

Comparison of compliance between serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis

International clinical psychopharmacology, 1995-01, Vol.9 Suppl 4, p.33-40

1995

Volltextzugriff (PDF)

Predictors of response to pharmacotherapy with citalopram in obsessive-compulsive disorder

International clinical psychopharmacology, 2001-11, Vol.16 (6), p.357-361

2001

Volltextzugriff (PDF)

Milnacipran, a new serotonin and noradrenaline reuptake inhibitor: an overview of its antidepressant activity and clinical tolerability

International clinical psychopharmacology, 1997-03, Vol.12 (2), p.99-108

1997

Volltextzugriff (PDF)

Prevalence of anxiety disorders comorbidity in bipolar depression, unipolar depression and dysthymia

Journal of affective disorders, 1997-02, Vol.42 (2), p.145-153

1997

Volltextzugriff (PDF)

Identification of candidate genes for chicken early- and late-feathering

Poultry science, 2016-07, Vol.95 (7), p.1498-1503

2016

Volltextzugriff (PDF)

Fluvoxamine prevents recurrence of depression: results of a long-term, double-blind, placebo-controlled study

International clinical psychopharmacology, 1998-03, Vol.13 (2), p.55-62

1998

Volltextzugriff (PDF)

ECNP consensus meeting March 2003 guidelines for the investigation of efficacy in substance use disorders

European neuropsychopharmacology, 2006-04, Vol.16 (3), p.224-230

2006

Volltextzugriff (PDF)

A 24-week study of 20 mg citalopram, 40 mg citalopram, and placebo in the prevention of relapse of major depression

International clinical psychopharmacology, 1993, Vol.8 (3), p.181-188

1993

Volltextzugriff (PDF)

Predicting response: noradrenaline reuptake inhibition

International clinical psychopharmacology, 1999-05, Vol.14 (3 Suppl 1), p.S21-S26

Montgomery, Stuart A

1999

Volltextzugriff (PDF)

Rapid onset of action of venlafaxine

International clinical psychopharmacology, 1995-03, Vol.10 Suppl 2, p.21-28

Montgomery, S A

1995

Volltextzugriff (PDF)

Is there a role for a pure noradrenergic drug in the treatment of depression?

European neuropsychopharmacology, 1997-04, Vol.7 (1), p.S3-S9

Montgomery, Stuart A.

1997

Volltextzugriff (PDF)

Moclobemide is effective and well tolerated in the long-term pharmacotherapy of social anxiety disorder with or without comorbid anxiety disorder

International clinical psychopharmacology, 2002-07, Vol.17 (4), p.161-170

2002

Volltextzugriff (PDF)

Efficacy and safety of the selective serotonin reuptake inhibitors in treating depression in elderly patients

International clinical psychopharmacology, 1998-09, Vol.13 (5 Suppl 5), p.S49-S54

Montgomery, S A

1998

Volltextzugriff (PDF)

Social phobia: long-term treatment outcome and prediction of response - a moclobemide study

International clinical psychopharmacology, 1997-09, Vol.12 (5), p.239-254

1997

Volltextzugriff (PDF)

Efficacy and tolerability of milnacipran: an overview

International clinical psychopharmacology, 1996-09, Vol.11 Suppl 4, p.47-47

1996

Volltextzugriff (PDF)

1 – 25 von 48.927

Suche als RSS-Feed

Aktive Filter

KollektionWiley Online Library - AutoHoldings Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30.847)
Mit Volltextzugriff
(35.341)

Publikationsform

13 weitere anzeigen...

Weniger anzeigen...

Sprache

12 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(16.890)
Life Sciences & Biomedicine
(12.150)
Humans
(9.212)
Female
(4.766)
Male
(4.677)
Physical Sciences
(3.328)
Biological And Medical Sciences
(3.274)
Animals
(2.855)
Adult
(2.799)
Social Sciences
(2.445)
Middle Aged
(2.406)
Medical Sciences
(2.302)
Technology
(1.979)
Aged
(1.766)
Physics
(1.584)
Adolescent
(1.311)
General & Internal Medicine
(1.198)
Fundamental And Applied Biological Sciences. Psychology
(1.176)
Chemistry
(1.126)
Surgery
(1.077)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Free E-Journal (出版社公開部分のみ）
(14.352)
Ingenta
(13.437)
MEDLINE
(11.913)
Single Journals
(9.546)
Journals@Ovid Complete
(8.573)
Elsevier ScienceDirect Journals Complete
(6.231)
Jstor Complete Legacy
(5.893)
IngentaConnect Journals
(5.015)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(4.102)
Ebook Central Perpetual and DDA
(3.585)
eBooks on EBSCOhost
(3.259)
Nexis Uni
(2.600)
Springer Nature - Complete Springer Journals
(2.199)
Taylor & Francis
(2.068)
Taylor & Francis Online
(2.030)
Taylor & Francis Journals
(2.011)
Business Source Ultimate【Trial: -2024/12/31】【Remote access available】
(1.938)
De Gruyter eBooks
(1.903)
SAGE Complete
(1.830)
ProQuest Dissertations & Theses A&I
(1.765)
Wiley Online Library
(0)

16 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Plos One
(351)
Against The Grain
(345)
Review Of Optometry
(275)
The New York Times
(275)
Journal Of The American Chemical Society
(250)
The Washingtonian
(248)
New York Times
(245)
Blood
(226)
Design Week
(224)
Science
(220)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Antidepressant medications: a review of the evidence for drug-induced sexual dysfunction

A Randomised Study Comparing Escitalopram with Venlafaxine XR in Primary Care Patients with Major Depressive Disorder

Absence of discontinuation symptoms with agomelatine and occurrence of discontinuation symptoms with paroxetine: a randomized, double-blind, placebo-controlled discontinuation study

Disabilities and quality of life in pure and comorbid generalized anxiety disorder and major depression in a national survey

Citalopram 20 mg, 40 mg and 60 mg are all effective and well tolerated compared with placebo in obsessive-compulsive disorder

Safety of mirtazapine: a review

Social phobia: diagnosis and epidemiology, neurobiology and pharmacology, comorbidity and treatment

Paroxetine is better than placebo in relapse prevention and the prophylaxis of recurrent depression

A meta-analysis of the efficacy and tolerability of paroxetine versus tricyclic antidepressants in the treatment of major depression

Mirtazapine versus amitriptyline in the long-term treatment of depression: a double-blind placebo-controlled study

Comparison of compliance between serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis

Predictors of response to pharmacotherapy with citalopram in obsessive-compulsive disorder

Milnacipran, a new serotonin and noradrenaline reuptake inhibitor: an overview of its antidepressant activity and clinical tolerability

Prevalence of anxiety disorders comorbidity in bipolar depression, unipolar depression and dysthymia

Identification of candidate genes for chicken early- and late-feathering

Fluvoxamine prevents recurrence of depression: results of a long-term, double-blind, placebo-controlled study

ECNP consensus meeting March 2003 guidelines for the investigation of efficacy in substance use disorders

A 24-week study of 20 mg citalopram, 40 mg citalopram, and placebo in the prevention of relapse of major depression

Predicting response: noradrenaline reuptake inhibition

Rapid onset of action of venlafaxine

Is there a role for a pure noradrenergic drug in the treatment of depression?

Moclobemide is effective and well tolerated in the long-term pharmacotherapy of social anxiety disorder with or without comorbid anxiety disorder

Efficacy and safety of the selective serotonin reuptake inhibitors in treating depression in elderly patients

Social phobia: long-term treatment outcome and prediction of response - a moclobemide study

Efficacy and tolerability of milnacipran: an overview

Aktive Filter

Suchergebnisse filtern